NO20075091L - Fremgangsmate for rensing av antistoffer - Google Patents

Fremgangsmate for rensing av antistoffer

Info

Publication number
NO20075091L
NO20075091L NO20075091A NO20075091A NO20075091L NO 20075091 L NO20075091 L NO 20075091L NO 20075091 A NO20075091 A NO 20075091A NO 20075091 A NO20075091 A NO 20075091A NO 20075091 L NO20075091 L NO 20075091L
Authority
NO
Norway
Prior art keywords
procedure
ion exchange
purifying antibodies
immunoglobulin
purification
Prior art date
Application number
NO20075091A
Other languages
English (en)
Other versions
NO345362B1 (no
Inventor
Roberto Falkenstein
Burkhard Kolb
Maria Sebald
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34936911&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075091(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20075091L publication Critical patent/NO20075091L/no
Publication of NO345362B1 publication Critical patent/NO345362B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments

Abstract

En fremgangsmåte for rensing av immunglobuliner ved ionebytterkromatografi er beskrevet. Den kromatografiske metoden anvender en svak ionebytteresin og en ett trinns elueringsmetode for rensing av et immunglobulin. I tillegg er en fremgangsmåte for bestemmelse av saltkonsentrasjonen for ett trinns eluering av et immunglobulin fra en ionebytteresin beskrevet.
NO20075091A 2005-05-25 2007-10-09 Fremgangsmåte for rensing av antistoffer NO345362B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05011302 2005-05-25
PCT/EP2006/004863 WO2006125599A2 (en) 2005-05-25 2006-05-23 Method for the purification of antibodies

Publications (2)

Publication Number Publication Date
NO20075091L true NO20075091L (no) 2008-01-23
NO345362B1 NO345362B1 (no) 2020-12-28

Family

ID=34936911

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075091A NO345362B1 (no) 2005-05-25 2007-10-09 Fremgangsmåte for rensing av antistoffer

Country Status (18)

Country Link
US (3) US20090098660A1 (no)
EP (2) EP1888636B2 (no)
JP (1) JP4852602B2 (no)
KR (1) KR100967778B1 (no)
CN (1) CN101180317B (no)
AT (1) ATE525087T1 (no)
AU (1) AU2006251307B2 (no)
BR (1) BRPI0610201B8 (no)
CA (1) CA2607375C (no)
DK (1) DK1888636T4 (no)
ES (2) ES2373402T5 (no)
FI (1) FI1888636T4 (no)
IL (2) IL186338A (no)
MX (1) MX2007014269A (no)
NO (1) NO345362B1 (no)
PL (1) PL1888636T5 (no)
TW (2) TWI320788B (no)
WO (1) WO2006125599A2 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
RU2009148891A (ru) 2007-06-01 2011-07-20 Ф.Хоффманн-Ля Рош Аг (Ch) Очистка иммуноглобулина
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
AR067537A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
CN102171237A (zh) * 2008-08-14 2011-08-31 默沙东公司 使用蛋白a亲和色谱法纯化抗体的方法
KR101555740B1 (ko) 2010-03-10 2015-09-25 에프. 호프만-라 로슈 아게 면역글로불린 용액 정제 방법
MX2012011737A (es) * 2010-04-14 2012-11-16 Hoffmann La Roche Remocion de agregado de inmunoglobulina.
KR20130142128A (ko) * 2010-10-11 2013-12-27 애브비 인코포레이티드 단백질의 정제 방법
WO2012084829A1 (en) 2010-12-21 2012-06-28 F. Hoffmann-La Roche Ag Isoform enriched antibody preparation and method for obtaining it
EP3318571B1 (en) * 2011-03-16 2021-02-17 F. Hoffmann-La Roche AG Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase
EP2726496B1 (en) 2011-07-01 2018-04-04 F.Hoffmann-La Roche Ag Method for separation of monomeric polypeptides from aggregated polypeptides
US10481164B2 (en) * 2012-03-26 2019-11-19 Amgen Inc. Method for using light scattering in real time to directly monitor and control impurity removal in purification processes
EP3048109A4 (en) * 2013-09-17 2017-04-19 Kaneka Corporation Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom
KR101700580B1 (ko) 2013-10-30 2017-02-13 (주)셀트리온 양이온 교환 크로마토그래피를 이용한 항체의 아형 분리 방법
CA2960797A1 (en) 2014-11-06 2016-05-12 F. Hoffmann-La Roche Ag Fc-region variants with modified fcrn-binding and methods of use
GB2539420B (en) * 2015-06-16 2021-01-13 Cytiva Sweden Ab Determination of chromatography conditions
BR112018009881A2 (pt) * 2015-11-18 2018-11-13 Merck Patent Gmbh separação de proteína aperfeiçoada em cromatografia de troca iônica
CA3005484A1 (en) * 2015-11-18 2017-05-26 Merck Patent Gmbh Opposite ph-salt gradients for improved protein separations
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
EP3773969A1 (en) * 2018-04-03 2021-02-17 Merck Patent GmbH Cex chromatography media and low salt elution of target proteins from biopharmaceutical feeds
CN111068361B (zh) * 2018-10-22 2022-02-11 中国石油化工股份有限公司 一种己内酰胺离子交换装置及其再生方法
CN110066314B (zh) * 2019-04-01 2023-10-27 上海药明生物技术有限公司 一种高效提高多聚体分离分辨率的亲和纯化工艺
TW202128264A (zh) * 2019-09-25 2021-08-01 瑞士商赫孚孟拉羅股份公司 使用經預測之溶離緩衝鹽濃度的陽離子層析法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
JPS5598117A (en) 1979-01-17 1980-07-25 Chemo Sero Therapeut Res Inst Purification of gamma-globulin derivative
DE3271181D1 (en) * 1982-02-08 1986-06-19 Schweiz Serum & Impfinst Intravenously administrable human immunoglobuline and process for its preparation
JPS6042336A (ja) * 1983-08-18 1985-03-06 Nippon Seiyaku Kk 免疫グロブリンの製造方法
DE3640513A1 (de) 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US4983722A (en) 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
US5177194A (en) 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
ATE122054T1 (de) * 1990-03-22 1995-05-15 Biotest Pharma Gmbh Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates.
WO1992014832A1 (en) * 1991-02-26 1992-09-03 Ajinomoto Co., Inc. Processes for purifying human bcdf
DE69214709T2 (de) 1991-04-26 1997-02-20 Surface Active Ltd Neue Antikörper und Verfahren zu ihrer Verwendung
DE4118912C1 (no) 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
CA2113813C (en) 1991-08-14 2005-04-12 Paula M. Jardieu Immunoglobulin variants for specific fc epsilon receptors
DE69328135D1 (de) 1992-06-26 2000-04-27 Aetsrn Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren
FR2706466B1 (fr) * 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
IT1271461B (it) 1993-12-01 1997-05-28 Menarini Ricerche Sud Spa Anticorpo monoclonale bispecifico anti-cd3/anti-egfr,processo per la produzione e suo uso.
ES2129076T5 (es) 1993-12-27 2003-05-16 Zlb Bioplasma Ag Procedimiento para la preparacion de un concentrado de inmunoglobulina g anti-d y composicion farmaceutica que lo contiene.
US5429746A (en) † 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
FI952196A0 (fi) * 1995-05-08 1995-05-08 Suomen Punainen Risti Veripalv Framstaellning av immunoglobulin
IL121900A (en) 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
UA64742C2 (uk) 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ)
US6162904A (en) * 1997-12-24 2000-12-19 Alpha Therapeutic Corporation Manufacturing method for intraveneously administrable immune globulin and resultant product
ATE321066T1 (de) † 1998-05-06 2006-04-15 Genentech Inc Anti-her2 antikörperzusammensetzung
WO1999062936A1 (en) * 1998-06-01 1999-12-09 Genentech, Inc. Separation of protein monomers from aggregates by use of ion-exchange chromatography
ES2527915T3 (es) * 1998-06-09 2015-02-02 Csl Behring Ag Producto de inmunoglobulina G (IgG) líquido
DK1084147T3 (da) 1998-06-09 2004-10-25 Statens Seruminstitut Fremgangsmåde til fremstilling af immunglobuliner til administration og andre immunglobulinprodukter
US6441144B1 (en) * 1999-05-20 2002-08-27 Alpha Therapeutic Corporation Method for repairing dual virally inactivated immune globulin for intravenous administration
AU2001249574A1 (en) † 2000-03-29 2001-10-08 Ecokasa Incorporated Nitrogen reduction wastewater treatment system
SE0001128D0 (sv) 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
US6962700B1 (en) * 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
CA2478925C (en) * 2002-04-26 2016-06-07 Robert Lee Fahrner Non-affinity purification of proteins
ES2629602T5 (es) 2002-09-11 2021-06-08 Genentech Inc Purificación de proteínas
CN1490334A (zh) * 2002-10-18 2004-04-21 缪金明 基因特异性抗体的亲和纯化方法
EP1601697B1 (en) 2003-02-28 2007-05-30 Lonza Biologics plc Antibody purification by Protein A and ion exchange chromatography
AR045614A1 (es) 2003-09-10 2005-11-02 Hoffmann La Roche Anticuerpos contra el recepctor de la interleuquina- 1 y los usos de los mismos
NZ551180A (en) * 2004-06-01 2009-10-30 Genentech Inc Antibody drug conjugates and methods
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies

Also Published As

Publication number Publication date
ES2389641T3 (es) 2012-10-30
US20170183394A1 (en) 2017-06-29
KR20080017322A (ko) 2008-02-26
US20090098660A1 (en) 2009-04-16
PL1888636T3 (pl) 2012-02-29
WO2006125599A2 (en) 2006-11-30
ES2373402T5 (es) 2022-09-14
CN101180317A (zh) 2008-05-14
CA2607375A1 (en) 2006-11-30
JP4852602B2 (ja) 2012-01-11
US20140243508A1 (en) 2014-08-28
ES2389641T5 (es) 2021-06-10
DK1888636T4 (da) 2022-07-18
EP1888636A2 (en) 2008-02-20
BRPI0610201A2 (pt) 2010-06-01
EP2261252B2 (en) 2020-10-21
TW200946543A (en) 2009-11-16
EP2261252A2 (en) 2010-12-15
IL186338A (en) 2011-01-31
NO345362B1 (no) 2020-12-28
TWI391399B (zh) 2013-04-01
WO2006125599A3 (en) 2007-06-21
FI1888636T4 (fi) 2023-01-31
EP2261252B1 (en) 2012-07-25
ATE525087T1 (de) 2011-10-15
EP1888636B1 (en) 2011-09-21
EP2261252A3 (en) 2011-03-23
BRPI0610201B1 (pt) 2020-12-29
BRPI0610201B8 (pt) 2021-05-25
AU2006251307B2 (en) 2011-08-04
PL1888636T5 (pl) 2023-03-06
CA2607375C (en) 2014-01-21
US9631007B2 (en) 2017-04-25
CA2607375F (en) 2006-11-30
TWI320788B (en) 2010-02-21
EP1888636B2 (en) 2022-03-30
JP2008542218A (ja) 2008-11-27
AU2006251307A1 (en) 2006-11-30
DK1888636T3 (da) 2011-11-14
US11034754B2 (en) 2021-06-15
TW200716669A (en) 2007-05-01
CN101180317B (zh) 2013-06-19
ES2373402T3 (es) 2012-02-03
IL186338A0 (en) 2008-01-20
KR100967778B1 (ko) 2010-07-05
IL206993A0 (en) 2012-01-01
MX2007014269A (es) 2008-01-24

Similar Documents

Publication Publication Date Title
NO20075091L (no) Fremgangsmate for rensing av antistoffer
WO2010048192A3 (en) Viral inactivation during purification of antibodies
ATE363491T1 (de) Reinigung von antikörpern durch protein a und ionenaustauschromatographie
EA201592192A1 (ru) Способ очистки моноклональных антител
ATE425989T1 (de) Proteinreinigungsverfahren
DE602005022239D1 (de) Festphase zur Verwendung in einem Verfahren zur Reinigung von Albuminkonjugaten
EP1568710A3 (en) Antibody purification method
SE0400501D0 (sv) Antibody purification
ATE384742T1 (de) Verfahren zur reinigung von preproinsulin
WO2011146179A3 (en) Apparatus and process of purification of proteins
WO2005090403A3 (en) Method and apparatus for antibody purification
WO2011090719A3 (en) Protein purification by ion exchange
DE602004023626D1 (de) Trennung von polypeptiden mit einer racemisierten aminosäure
EP1780537A4 (en) PROTEOMANALYSIS PROCESS FOR PHOSPHORYLATED PROTEIN
SE0300791D0 (sv) Use of ph-responsive polymers
NO20080131L (no) Fremgangsmate for rensing av IL-18 bindende protein
ATE461199T1 (de) Verfahren zur trennung und reinigung von hydrocodon durch präparative chromatographie
WO2012099949A3 (en) Antibody purification via affinity chromatography
DK1558622T3 (da) Fremgangsmåde til oprensning af macrolider
HRP20080408T3 (en) Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain
DK1371665T3 (da) Fremgangsmåde for selektivt at isolere IgY-antistoffer fra æggeblomme af en andefugl
DE602004018674D1 (de) Grosstechnisches verfahren zur abtrennung und aufreinigung von fentanyl durch präparative umkehrphasenchromatographie
DK1471355T3 (da) Fremgangsmåde til fastgörelse af biomolekyle til bærer
EP2129461A4 (en) CLEANING OF IMMUNOGLOBULINS
RU2008138372A (ru) СПОСОБ ОЧИСТКИ РЕКОМБИНАНТНОГО ФАКТОРА VIIa ЧЕЛОВЕКА